These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10863887)

  • 1. Variations in response to citalopram in men and women with alcohol dependence.
    Naranjo CA; Knoke DM; Bremner KE
    J Psychiatry Neurosci; 2000 May; 25(3):269-75. PubMed ID: 10863887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using fuzzy logic to predict response to citalopram in alcohol dependence.
    Naranjo CA; Bremner KE; Bazoon M; Turksen IB
    Clin Pharmacol Ther; 1997 Aug; 62(2):209-24. PubMed ID: 9284858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Juva K; Alho H
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram and quality of life in lung transplant recipients.
    Silvertooth EJ; Doraiswamy PM; Clary GL; Babyak MA; Wilkerson N; Hellegars C; Palmer SM
    Psychosomatics; 2004; 45(3):271-2. PubMed ID: 15123855
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
    Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
    J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.
    Naranjo CA; Poulos CX; Bremner KE; Lanctôt KL
    Clin Pharmacol Ther; 1992 Jun; 51(6):729-39. PubMed ID: 1535302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.
    Heffner JL; Tran GQ; Johnson CS; Barrett SW; Blom TJ; Thompson RD; Anthenelli RM
    J Stud Alcohol Drugs; 2010 Jan; 71(1):61-70. PubMed ID: 20105415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
    Porsteinsson AP; Drye LT; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG;
    JAMA; 2014 Feb; 311(7):682-91. PubMed ID: 24549548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram reduces endotoxin-induced fatigue.
    Hannestad J; DellaGioia N; Ortiz N; Pittman B; Bhagwagar Z
    Brain Behav Immun; 2011 Feb; 25(2):256-9. PubMed ID: 20955776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of citalopram on alcohol intake in heavy drinkers.
    Balldin J; Berggren U; Engel J; Eriksson M; Hård E; Söderpalm B
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1133-6. PubMed ID: 7847595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Symptom Trajectories as Predictors of Treatment Outcome for Citalopram Versus Placebo.
    Zilcha-Mano S; Roose SP; Brown PJ; Rutherford BR
    Am J Geriatr Psychiatry; 2017 Jun; 25(6):654-661. PubMed ID: 28318797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram: a comprehensive review.
    Pollock BG
    Expert Opin Pharmacother; 2001 Apr; 2(4):681-98. PubMed ID: 11336616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.